Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

Leadership changes afoot at two CGT biotechs

Legend Biotech’s CEO stepped down without warning, while Sarepta has appointed a biopharma veteran to take the company forward.

Robert Barrie

News

Argenx signs agreement to buy Forte Biosciences for $2.2bn

Salong Debbarma

News

Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development

Annabel Kartal Allen

News

BioMarin and n-Lorem partner on early research for ReNU syndrome therapy

News

Outlook Therapeutics wins FDA approval for Lytenava in wet AMD

Features

Magazine: Made in the USA

News

Kenvue’s Tylenol with Naproxen gains FDA approval

News

Sanofi abandons eczema drug approval efforts in another blow to OX40 class

Analysis

Comment

Why the India-UK trade deal now needs a five-gate implementation ledger

Ross Law

Analyst Comment

Adult epilepsy market to reach $17.bn across 7MM by 2035

GlobalData Healthcare

Analyst Comment

Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing

GlobalData Healthcare

Analyst Comment

Samsung Biologics: geographic diversification is a sound business decision

Dominic Tyer

Themes

News

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

BMS enhances its AI computing power as big pharma race to stay competitive within the shifting global landscape.

More themes

Partner Content

Turning AI skeptics into AI advocates through high-integrity data

Partner Content

Keeping pace with generative AI in pharmaceutical and healthcare organisations

Analyst Comment

Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development

Partner Content

Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape

$3495.00

Industry Insights: How Dietary Supplements Have Evolved Beyond Traditional Health Management

$1950.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Argenx signs agreement to buy Forte Biosciences for $2.2bn

Apnimed scouts $160m IPO to back late-stage sleep apnoea pill development

BioMarin and n-Lorem partner on early research for ReNU syndrome therapy

Outlook Therapeutics wins FDA approval for Lytenava in wet AMD

Magazine: Made in the USA

Kenvue’s Tylenol with Naproxen gains FDA approval

Sanofi abandons eczema drug approval efforts in another blow to OX40 class

Why the India-UK trade deal now needs a five-gate implementation ledger

Adult epilepsy market to reach $17.bn across 7MM by 2035

Speciality versus diversity: the four-way CDMO race in outsourced HPAPI manufacturing

Samsung Biologics: geographic diversification is a sound business decision

Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Merger and Acquisition Trends in Pharma - Q2 2026

Venture Capital Investment Trends in Pharma - Q2 2026

Emerging Market Outsourcing Report, Q2 2026

Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape

Industry Insights: How Dietary Supplements Have Evolved Beyond Traditional Health Management

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Merger and Acquisition Trends in Pharma - Q2 2026

Venture Capital Investment Trends in Pharma - Q2 2026

Emerging Market Outsourcing Report, Q2 2026

Focal Segmental Glomerulosclerosis (FSGS): Market View, Current and Future Competitive Landscape

Industry Insights: How Dietary Supplements Have Evolved Beyond Traditional Health Management

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing